Oblongine is primarily studied for its potential anti-cancer properties, particularly in inhibiting the growth of certain tumor cells. It has shown activity in inducing apoptosis and suppressing proliferation in liver and lung cancer cell lines. Research also suggests it may modulate signaling pathways involved in cell survival and inflammation, making it a candidate for further investigation in oncology and immunomodulatory therapies. Additionally, oblongine has been explored for its antimicrobial effects, demonstrating inhibitory action against some pathogenic bacteria and fungi. Its natural origin and bioactivity support interest in its use as a lead compound for drug development.